D-0645-2025 Class II Ongoing
FDA drug recall D-0645-2025 was initiated by Ascend Laboratories, LLC on Aug 28, 2025 and is designated Class II. Reason for recall: Superpotent drug The recall status is ongoing. Affected quantity: 2,256 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 24, 2025
- Initiation Date
- Aug 28, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,256 bottles
Product description
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-432-03
Reason for recall
Superpotent drug
Distribution pattern
Nationwide in the USA.
Code information
Lot #: 24144162, Exp. Date 09/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0645-2025
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Ascend Laboratories, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.